Alpha Teknova, Inc. (TKNO)
Alpha Teknova, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Hollister, CA, US. The stock last traded at $7.24, up 2.84% on the session, giving a market capitalisation of $388.2M. On trailing twelve-month figures it carries a trailing P/E of -22.98, a net margin of -38.4%. Its beta of 0.68 implies it has historically moved less than the broad market.
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
Alpha Teknova, Inc. is most often compared with the following Healthcare names: